Corbus Pharmaceuticals

-$0.0177 (-3.71%) As of 8:32 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBP and other ETFs, options, and stocks.

About CRBP

Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes.

CEO
Yuval Cohen
Employees
76
Headquarters
Norwood, Massachusetts
Founded
2009

CRBP Key Statistics

Market cap
57.56M
Price-Earnings ratio
—
Dividend yield
—
Average volume
757.23K
High today
$0.499
Low today
$0.4526
Open price
$0.496
Volume
471.36K
52 Week high
$4.00
52 Week low
$0.404

CRBP Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure